JP2022536669A5 - - Google Patents

Info

Publication number
JP2022536669A5
JP2022536669A5 JP2021573344A JP2021573344A JP2022536669A5 JP 2022536669 A5 JP2022536669 A5 JP 2022536669A5 JP 2021573344 A JP2021573344 A JP 2021573344A JP 2021573344 A JP2021573344 A JP 2021573344A JP 2022536669 A5 JP2022536669 A5 JP 2022536669A5
Authority
JP
Japan
Prior art keywords
risdiplam
midazolam
pharmaceutical composition
patients
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573344A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536669A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066003 external-priority patent/WO2020249577A1/en
Publication of JP2022536669A publication Critical patent/JP2022536669A/ja
Publication of JP2022536669A5 publication Critical patent/JP2022536669A5/ja
Pending legal-status Critical Current

Links

JP2021573344A 2019-06-12 2020-06-10 Smaの新規治療 Pending JP2022536669A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19179563.2 2019-06-12
EP19179563 2019-06-12
PCT/EP2020/066003 WO2020249577A1 (en) 2019-06-12 2020-06-10 New treatment of sma

Publications (2)

Publication Number Publication Date
JP2022536669A JP2022536669A (ja) 2022-08-18
JP2022536669A5 true JP2022536669A5 (cg-RX-API-DMAC10.html) 2023-06-16

Family

ID=66826852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573344A Pending JP2022536669A (ja) 2019-06-12 2020-06-10 Smaの新規治療

Country Status (5)

Country Link
US (1) US20220168307A1 (cg-RX-API-DMAC10.html)
EP (1) EP3982970A1 (cg-RX-API-DMAC10.html)
JP (1) JP2022536669A (cg-RX-API-DMAC10.html)
CN (1) CN113966219A (cg-RX-API-DMAC10.html)
WO (1) WO2020249577A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4197536A1 (en) * 2021-12-20 2023-06-21 Universitat de València Haloperidol for use in the treatment of spinal muscular atrophy
CN118005654A (zh) * 2022-04-18 2024-05-10 深圳市塔吉瑞生物医药有限公司 取代的吡啶并嘧啶酮类化合物及包含该化合物的组合物及其用途
CN117250301B (zh) * 2023-11-20 2024-02-09 中国医学科学院北京协和医院 一种定量检测人血浆中诺西那生的液相质谱联用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130964D0 (en) 2001-12-24 2002-02-13 Special Products Ltd Pharmaceutical composition
AU2015261046C1 (en) 2014-05-15 2019-07-25 F. Hoffmann-La Roche Ag Compounds for treating spinal muscular atrophy
AU2016353961B2 (en) 2015-11-12 2019-08-29 F. Hoffmann-La Roche Ag Compositions for treating spinal muscular atrophy
ES3072590T3 (en) * 2017-10-03 2026-07-02 Hoffmann La Roche New treatment of sma

Similar Documents

Publication Publication Date Title
RU2176507C2 (ru) Пероральные жидкие композиции, содержащие алендронат
JP6353577B2 (ja) 組み合わせ組成物
EP3003384B1 (en) Oral solution comprising atomoxetine hydrochloride
JP2006518751A (ja) 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
CZ154997A3 (en) Lyophilized preparation for oral administration
ES2333805T3 (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
JP2008512453A (ja) 胃酸の急速かつ持続的な抑制のための製剤、オメプラゾール制酸剤複合体−即時放出物
SK146297A3 (en) Composition comprising amoxycillin and clavulanic acid
CN120091814A (zh) 用slc6a19功能的哌啶抑制剂治疗pku的给药方案
CA2350857A1 (en) The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
ES2763437T3 (es) Composición para el tratamiento de la esterilidad
WO2020155507A1 (zh) 一种不含防腐剂的固体剂型氨己烯酸药物组合物
US8153824B2 (en) Antidepressant oral liquid compositions
IL276838A (en) Oral formulation and suspension of an oncology drug
CN115227658A (zh) 一种氨己烯酸固体制剂组合物
ES2309357T3 (es) Nueva combinacion sinergica que comprende roflumilast y formoterol.
WO2013173803A2 (en) Formulations of amoxicillin and clavulanate potassium and methods for using same
JP7270901B2 (ja) 男性の避妊のための非ホルモン性組成物および方法
JP2025026838A (ja) レボケトコナゾールによる疾患の処置方法
IL323792A (en) New treatment of sma
EP3897579A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
CN1372468A (zh) 羟乙磷酸二钠口服制剂
KR20200083971A (ko) 칼슘 보충용 조성물
WO2012066401A1 (en) Stable oral pharmaceutical compositions of montelukast
US20200375897A1 (en) Composition for calcium supplementation